annual net income:
-$4.03M-$56.19M(-107.73%)Summary
- As of today (June 4, 2025), LGND annual net profit is -$4.03 million, with the most recent change of -$56.19 million (-107.73%) on December 31, 2024.
- During the last 3 years, LGND annual net income has fallen by -$61.17 million (-107.06%).
- LGND annual net income is now -100.64% below its all-time high of $629.30 million, reached on December 31, 2019.
Performance
LGND Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
-$42.45M-$11.36M(-36.55%)Summary
- As of today (June 4, 2025), LGND quarterly net profit is -$42.45 million, with the most recent change of -$11.36 million (-36.55%) on March 31, 2025.
- Over the past year, LGND quarterly net income has dropped by -$128.59 million (-149.28%).
- LGND quarterly net income is now -106.37% below its all-time high of $666.34 million, reached on March 31, 2019.
Performance
LGND quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
-$132.62M-$128.59M(-3189.24%)Summary
- As of today (June 4, 2025), LGND TTM net profit is -$132.62 million, with the most recent change of -$128.59 million (-3189.24%) on March 31, 2025.
- Over the past year, LGND TTM net income has dropped by -$228.97 million (-237.65%).
- LGND TTM net income is now -117.35% below its all-time high of $764.38 million, reached on March 31, 2019.
Performance
LGND TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
LGND Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -107.7% | -149.3% | -237.7% |
| 3 y3 years | -107.1% | -175.9% | -660.8% |
| 5 y5 years | -100.6% | -75.9% | -116.8% |
LGND Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -107.1% | +87.9% | -149.3% | +18.2% | -237.7% | at low |
| 5 y | 5-year | -100.6% | +87.9% | -149.3% | +18.2% | -237.7% | at low |
| alltime | all time | -100.6% | +96.6% | -106.4% | +39.0% | -117.3% | +8.7% |
LGND Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$42.45M(+36.6%) | -$132.62M(+3189.2%) |
| Dec 2024 | -$4.03M(-107.7%) | -$31.09M(+333.5%) | -$4.03M(-108.9%) |
| Sep 2024 | - | -$7.17M(-86.2%) | $45.24M(+7.4%) |
| Jun 2024 | - | -$51.91M(-160.3%) | $42.14M(-56.3%) |
| Mar 2024 | - | $86.14M(+373.6%) | $96.34M(+84.7%) |
| Dec 2023 | $52.15M(-256.3%) | $18.19M(-277.0%) | $52.15M(+216.4%) |
| Sep 2023 | - | -$10.27M(-548.6%) | $16.48M(-39.3%) |
| Jun 2023 | - | $2.29M(-94.5%) | $27.16M(+13.3%) |
| Mar 2023 | - | $41.95M(-339.9%) | $23.97M(-171.9%) |
| Dec 2022 | -$33.36M(-158.4%) | -$17.48M(-4428.0%) | -$33.36M(+56.7%) |
| Sep 2022 | - | $404.00K(-145.1%) | -$21.29M(+167.1%) |
| Jun 2022 | - | -$895.00K(-94.2%) | -$7.97M(-133.7%) |
| Mar 2022 | - | -$15.38M(+184.1%) | $23.65M(-58.6%) |
| Dec 2021 | $57.14M(-2014.2%) | -$5.42M(-139.5%) | $57.14M(-16.4%) |
| Sep 2021 | - | $13.72M(-55.3%) | $68.31M(+42.6%) |
| Jun 2021 | - | $30.73M(+69.7%) | $47.89M(+22.0%) |
| Mar 2021 | - | $18.11M(+214.3%) | $39.25M(-1415.0%) |
| Dec 2020 | -$2.98M(-100.5%) | $5.76M(-186.0%) | -$2.98M(-81.5%) |
| Sep 2020 | - | -$6.70M(-130.3%) | -$16.11M(-34.7%) |
| Jun 2020 | - | $22.09M(-191.5%) | -$24.66M(-59.7%) |
| Mar 2020 | - | -$24.13M(+227.6%) | -$61.17M(-109.7%) |
| Dec 2019 | $629.30M(+339.1%) | -$7.37M(-51.7%) | $629.30M(+5.9%) |
| Sep 2019 | - | -$15.25M(+5.8%) | $594.18M(-12.2%) |
| Jun 2019 | - | -$14.42M(-102.2%) | $676.80M(-11.5%) |
| Mar 2019 | - | $666.34M(-1668.5%) | $764.38M(+433.3%) |
| Dec 2018 | $143.32M(+1041.5%) | -$42.48M(-163.1%) | $143.32M(-19.8%) |
| Sep 2018 | - | $67.36M(-7.9%) | $178.79M(+49.2%) |
| Jun 2018 | - | $73.16M(+61.6%) | $119.86M(+127.2%) |
| Mar 2018 | - | $45.28M(-745.9%) | $52.75M(+320.2%) |
| Dec 2017 | $12.56M(-867.5%) | -$7.01M(-183.2%) | $12.55M(-23.6%) |
| Sep 2017 | - | $8.43M(+39.1%) | $16.44M(+81.4%) |
| Jun 2017 | - | $6.06M(+19.3%) | $9.06M(-386.2%) |
| Mar 2017 | - | $5.08M(-262.5%) | -$3.17M(+93.4%) |
| Dec 2016 | -$1.64M(-100.7%) | -$3.13M(-397.4%) | -$1.64M(-120.9%) |
| Sep 2016 | - | $1.05M(-117.0%) | $7.83M(-96.2%) |
| Jun 2016 | - | -$6.17M(-193.4%) | $205.94M(-12.6%) |
| Mar 2016 | - | $6.61M(+4.2%) | $235.68M(+2.5%) |
| Dec 2015 | $229.82M(+1811.4%) | $6.34M(-96.8%) | $229.82M(-0.3%) |
| Sep 2015 | - | $199.16M(+745.2%) | $230.54M(+606.0%) |
| Jun 2015 | - | $23.56M(+3025.2%) | $32.65M(+205.7%) |
| Mar 2015 | - | $754.00K(-89.3%) | $10.68M(-11.2%) |
| Dec 2014 | $12.02M(+5.3%) | $7.05M(+451.2%) | $12.02M(+75.8%) |
| Sep 2014 | - | $1.28M(-19.6%) | $6.84M(-9.1%) |
| Jun 2014 | - | $1.59M(-24.1%) | $7.52M(-37.4%) |
| Mar 2014 | - | $2.10M(+12.2%) | $12.02M(+5.3%) |
| Dec 2013 | $11.42M(-2267.0%) | $1.87M(-4.9%) | $11.42M(+7.6%) |
| Sep 2013 | - | $1.97M(-67.7%) | $10.61M(+25.5%) |
| Jun 2013 | - | $6.09M(+307.4%) | $8.46M(-5224.2%) |
| Mar 2013 | - | $1.50M(+40.6%) | -$165.00K(-68.7%) |
| Dec 2012 | -$527.00K(-105.4%) | $1.06M(-647.9%) | -$527.00K(-117.0%) |
| Sep 2012 | - | -$194.00K(-92.3%) | $3.10M(-448.6%) |
| Jun 2012 | - | -$2.53M(-323.2%) | -$888.00K(-172.8%) |
| Mar 2012 | - | $1.13M(-75.8%) | $1.22M(-87.4%) |
| Dec 2011 | $9.71M(-193.7%) | $4.69M(-212.2%) | $9.71M(+1.9%) |
| Sep 2011 | - | -$4.18M(+890.0%) | $9.53M(+411.4%) |
| Jun 2011 | - | -$422.00K(-104.4%) | $1.86M(-6.9%) |
| Mar 2011 | - | $9.63M(+113.7%) | $2.00M(-119.3%) |
| Dec 2010 | -$10.37M(+432.5%) | $4.50M(-138.0%) | -$10.37M(-12.4%) |
| Sep 2010 | - | -$11.84M(+4084.8%) | -$11.84M(-755.6%) |
| Jun 2010 | - | -$283.00K(-89.7%) | $1.81M(+329.0%) |
| Mar 2010 | - | -$2.75M(-190.6%) | $421.00K(-121.6%) |
| Dec 2009 | -$1.95M | $3.04M(+68.4%) | -$1.95M(-97.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | $1.80M(-208.1%) | -$74.61M(-21.1%) |
| Jun 2009 | - | -$1.67M(-67.4%) | -$94.54M(-4.8%) |
| Mar 2009 | - | -$5.12M(-92.7%) | -$99.30M(+1.2%) |
| Dec 2008 | -$98.11M(-134.8%) | -$69.63M(+284.1%) | -$98.11M(+335.1%) |
| Sep 2008 | - | -$18.13M(+181.9%) | -$22.55M(+610.0%) |
| Jun 2008 | - | -$6.43M(+63.5%) | -$3.18M(-192.5%) |
| Mar 2008 | - | -$3.93M(-166.2%) | $3.43M(-98.8%) |
| Dec 2007 | $281.69M(-987.4%) | $5.94M(+375.8%) | $281.69M(-32.5%) |
| Sep 2007 | - | $1.25M(+589.5%) | $417.11M(+4.0%) |
| Jun 2007 | - | $181.00K(-99.9%) | $400.95M(+4.2%) |
| Mar 2007 | - | $274.32M(+94.1%) | $384.81M(+297.5%) |
| Dec 2006 | -$31.74M(-12.8%) | $141.36M(-1047.5%) | $96.80M(-304.7%) |
| Sep 2006 | - | -$14.92M(-6.5%) | -$47.29M(+22.4%) |
| Jun 2006 | - | -$15.96M(+16.6%) | -$38.65M(+22.3%) |
| Mar 2006 | - | -$13.69M(+402.8%) | -$31.61M(-13.1%) |
| Dec 2005 | -$36.40M(-19.4%) | -$2.72M(-56.7%) | -$36.40M(+122.7%) |
| Sep 2005 | - | -$6.28M(-29.6%) | -$16.34M(-42.8%) |
| Jun 2005 | - | -$8.92M(-51.7%) | -$28.56M(-31.5%) |
| Mar 2005 | - | -$18.47M(-206.6%) | -$41.70M(-7.6%) |
| Dec 2004 | -$45.14M(-53.2%) | $17.33M(-193.7%) | -$45.14M(-60.9%) |
| Sep 2004 | - | -$18.50M(-16.2%) | -$115.54M(+6.9%) |
| Jun 2004 | - | -$22.07M(+0.7%) | -$108.13M(+10.3%) |
| Mar 2004 | - | -$21.91M(-58.7%) | -$98.06M(+1.7%) |
| Dec 2003 | -$96.47M(+84.6%) | -$53.07M(+378.6%) | -$96.47M(+38.2%) |
| Sep 2003 | - | -$11.09M(-7.6%) | -$69.79M(+6.1%) |
| Jun 2003 | - | -$12.00M(-41.0%) | -$65.75M(-0.4%) |
| Mar 2003 | - | -$20.32M(-23.0%) | -$66.00M(+26.3%) |
| Dec 2002 | -$52.26M(+21.5%) | -$26.39M(+274.5%) | -$52.26M(+34.3%) |
| Sep 2002 | - | -$7.05M(-42.5%) | -$38.92M(-1.8%) |
| Jun 2002 | - | -$12.25M(+86.3%) | -$39.62M(+4.3%) |
| Mar 2002 | - | -$6.58M(-49.6%) | -$37.99M(-11.6%) |
| Dec 2001 | -$42.99M(-40.6%) | -$13.05M(+68.6%) | -$42.99M(+0.8%) |
| Sep 2001 | - | -$7.74M(-27.0%) | -$42.64M(-11.7%) |
| Jun 2001 | - | -$10.62M(-8.3%) | -$48.30M(-10.8%) |
| Mar 2001 | - | -$11.58M(-8.8%) | -$54.15M(-24.2%) |
| Dec 2000 | -$72.38M(-3.1%) | -$12.70M(-5.2%) | -$71.47M(-12.4%) |
| Sep 2000 | - | -$13.40M(-18.6%) | -$81.59M(-5.7%) |
| Jun 2000 | - | -$16.46M(-43.1%) | -$86.48M(-2.9%) |
| Mar 2000 | - | -$28.91M(+26.7%) | -$89.03M(+19.1%) |
| Dec 1999 | -$74.72M(-36.6%) | -$22.82M(+24.7%) | -$74.72M(-19.3%) |
| Sep 1999 | - | -$18.30M(-3.7%) | -$92.60M(-23.2%) |
| Jun 1999 | - | -$19.00M(+30.1%) | -$120.60M(+1.3%) |
| Mar 1999 | - | -$14.60M(-64.1%) | -$119.00M(+0.9%) |
| Dec 1998 | -$117.90M(+17.7%) | -$40.70M(-12.1%) | -$117.90M(-18.9%) |
| Sep 1998 | - | -$46.30M(+166.1%) | -$145.30M(+31.4%) |
| Jun 1998 | - | -$17.40M(+28.9%) | -$110.60M(+6.8%) |
| Mar 1998 | - | -$13.50M(-80.2%) | -$103.60M(+3.4%) |
| Dec 1997 | -$100.20M(+168.6%) | -$68.10M(+487.1%) | -$100.20M(+128.2%) |
| Sep 1997 | - | -$11.60M(+11.5%) | -$43.90M(+7.9%) |
| Jun 1997 | - | -$10.40M(+3.0%) | -$40.70M(+1.0%) |
| Mar 1997 | - | -$10.10M(-14.4%) | -$40.30M(+8.0%) |
| Dec 1996 | -$37.30M(-41.9%) | -$11.80M(+40.5%) | -$37.30M(+10.0%) |
| Sep 1996 | - | -$8.40M(-16.0%) | -$33.90M(-0.3%) |
| Jun 1996 | - | -$10.00M(+40.8%) | -$34.00M(-48.1%) |
| Mar 1996 | - | -$7.10M(-15.5%) | -$65.50M(+2.0%) |
| Dec 1995 | -$64.20M(+136.9%) | -$8.40M(-1.2%) | -$64.20M(+3.0%) |
| Sep 1995 | - | -$8.50M(-79.5%) | -$62.30M(+3.7%) |
| Jun 1995 | - | -$41.50M(+615.5%) | -$60.10M(+131.2%) |
| Mar 1995 | - | -$5.80M(-10.8%) | -$26.00M(-4.1%) |
| Dec 1994 | -$27.10M | -$6.50M(+3.2%) | -$27.10M(+31.6%) |
| Sep 1994 | - | -$6.30M(-14.9%) | -$20.60M(+44.1%) |
| Jun 1994 | - | -$7.40M(+7.2%) | -$14.30M(+107.2%) |
| Mar 1994 | - | -$6.90M | -$6.90M |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual net profit?
- What is the all time high annual net income for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual net income year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly net profit?
- What is the all time high quarterly net income for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly net income year-on-year change?
- What is Ligand Pharmaceuticals Incorporated TTM net profit?
- What is the all time high TTM net income for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated TTM net income year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual net profit?
The current annual net income of LGND is -$4.03M
What is the all time high annual net income for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual net profit is $629.30M
What is Ligand Pharmaceuticals Incorporated annual net income year-on-year change?
Over the past year, LGND annual net profit has changed by -$56.19M (-107.73%)
What is Ligand Pharmaceuticals Incorporated quarterly net profit?
The current quarterly net income of LGND is -$42.45M
What is the all time high quarterly net income for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly net profit is $666.34M
What is Ligand Pharmaceuticals Incorporated quarterly net income year-on-year change?
Over the past year, LGND quarterly net profit has changed by -$128.59M (-149.28%)
What is Ligand Pharmaceuticals Incorporated TTM net profit?
The current TTM net income of LGND is -$132.62M
What is the all time high TTM net income for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high TTM net profit is $764.38M
What is Ligand Pharmaceuticals Incorporated TTM net income year-on-year change?
Over the past year, LGND TTM net profit has changed by -$228.97M (-237.65%)